At Booking.com, Innovation Means Constant Failure (Summer Repeat)
Transcript
During a busy travel season, digital travel platform Booking.com wanted to try an experiment that would mean changing the site's landing page. The CEO at the time, Gillian Tans, made the decision to lean into the company's 'test everything' culture—even if it meant failure.
In this episode from 2019, Harvard Business School Professor Stefan Thomke and host Brian Kenny discuss how past experience and intuition can be misleading when attempting to launch an innovative new product, service, business model, or process. Instead, Booking.com and other innovative firms embrace a culture where testing, experimentation, and even failure are at the heart of what they do.
As you plan your summer travels, enjoy this episode about cultivating an experimental mindset with insights from the case Booking.com and Professor Thomke's book Experimentation Works.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Up 10% in a week, is this FTSE 100 stock set to be the comeback story of 2025?
Diageo (LSE:DGE) shares are up 10% since the firm released its full-year earnings on Monday (4 August). I own shares in the FTSE 100 drinks company and I thought the results were… fine. Importantly though, both the firm's results and its forward guidance were ahead of analyst expectations. And a lot of the time, this is what makes share prices move in the short term. The results In the 12 months leading up to 30 June, Diageo reported organic sales growth of 1.7%, while earnings per share fell 0.7% due to increased investments in facilities. Neither of these numbers are particularly inspiring, but both are ahead of what analysts had been expecting. And that's part of the reason the stock's responded positively. The company's forward-looking guidance was much more positive. Diageo expects similar sales growth in 2026, but is looking to make a series of cost cuts, which should lead to 5% profit growth. This is very clearly better than investors had anticipated, but it's worth keeping things in context. And to be fair, the market's doing this – the stock's still down 22% since the start of the year. Not the end Until February, Diageo's official medium-term guidance was for organic revenue growth to be in the region of 6%. And with the firm set to achieve 1.7% again next year, that seems a long way off. Furthermore, while the plan to reduce costs might be a good one, it's not really a strategy for long-term growth. There's only so much cost-cutting to boost profits any business can do. After the Second Battle of El Alamein, Winston Churchill famously said: 'This is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning'. That's pretty much my view on Diageo at the moment. The business is a long way off where I might have hoped it would be, but it is – at least – starting to show signs of arresting the decline. Valuation Diageo's a fascinating stock. When things are going well, investors focus on its obvious strengths, but when they start to go wrong, the market sees nothing but threats. The truth – as is often the case – is probably somewhere in the middle. The FTSE 100 firm's brands and scale are a genuine strength, but GLP-1 drugs are also a very real challenge. That means the trick when it comes to buying the stock is to try and work out when investors are pessimistic and focusing on the negatives. That's when the shares trade at attractive prices. Despite the share price climbing 10% in the last week, I think this is still the case. A price-to-earnings (P/E) ratio of 16 is towards the lower end of where the stock has traded over the last five years. The comeback story of 2025? Diageo's set out a clear agenda for growth over the next 12 months. And this was definitely a positive surprise for the stock market, which is why the share price has jumped. I don't think the stock's going to be the comeback story of 2025. But I'm optimistic this might be the year when the company manages to stop the downturn of the last few years. I feel it's worth watching. The post Up 10% in a week, is this FTSE 100 stock set to be the comeback story of 2025? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Stephen Wright has positions in Diageo Plc. The Motley Fool UK has recommended Diageo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
Deutsche Telekom Second Quarter 2025 Earnings: Revenues In Line With Expectations
Explore Deutsche Telekom's Fair Values from the Community and select yours Deutsche Telekom (ETR:DTE) Second Quarter 2025 Results Key Financial Results Revenue: €29.3b (up 1.0% from 2Q 2024). Net income: €2.62b (up 25% from 2Q 2024). Profit margin: 8.9% (up from 7.2% in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Deutsche Telekom Meets Expectations Revenue was in line with analyst estimates. Looking ahead, revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Telecom industry in Europe. Performance of the market in Germany. The company's shares are down 5.2% from a week ago. Risk Analysis Before you take the next step you should know about the 1 warning sign for Deutsche Telekom that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
8 minutes ago
- Yahoo
Shareholders in Spirax Group (LON:SPX) are in the red if they invested three years ago
Explore Spirax Group's Fair Values from the Community and select yours For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term Spirax Group plc (LON:SPX) shareholders, since the share price is down 46% in the last three years, falling well short of the market return of around 62%. Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. Spirax Group saw its EPS decline at a compound rate of 6.6% per year, over the last three years. The share price decline of 19% is actually steeper than the EPS slippage. So it's likely that the EPS decline has disappointed the market, leaving investors hesitant to buy. The image below shows how EPS has tracked over time (if you click on the image you can see greater detail). We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. Dive deeper into the earnings by checking this interactive graph of Spirax Group's earnings, revenue and cash flow. What About Dividends? As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for Spirax Group the TSR over the last 3 years was -43%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence! A Different Perspective While the broader market gained around 22% in the last year, Spirax Group shareholders lost 18% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 7% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Spirax Group has 1 warning sign we think you should be aware of. Spirax Group is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
